This review summarizes pathological muscle differentiation focusing on the role played by DUX4 in FSHD muscle in order to better understand the pathophysiology of the disease and to provide novel possible therapeutic strategies targeting DUX4 aberrant expression. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.